Background:
Children treated for cancer are at risk of developing iron toxicity due
to receiving red cell transfusions and myelosuppressive chemotherapy.
Transfusions administered during prolonged episodes of marrow
suppression may increase exposure to toxic, reactive forms of iron and
thereby increase risk of extrahepatic iron accumulation and long-term
organ damage.